Latest period
$44.29M
YoY change
-55.1%
5Y CAGR
-20.8%
Peak year (2022)
$186.99M
Latest annual
$52.51M
Total Liabilities history chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: $52.51M
Total Liabilities growth chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: -55.1%
Total Liabilities history table for Tango Therapeutics (TNGX) from 2019 to 2025
| 2025 | $52.51M | -55.1% | −$64.46M | ||
| 2024 | $116.97M | -21.7% | −$32.48M | ||
| 2023 | $149.46M | -20.1% | −$37.53M | ||
| 2022 | $186.99M | +20.3% | +$31.59M | ||
| 2021 | $155.41M | -7.9% | −$13.24M | ||
| 2020 | $168.65M | +252.4% | +$120.79M | ||
| 2019 | $47.86M | — | — |
- 2025$52.51M-55.1%
- 2024$116.97M-21.7%
- 2023$149.46M-20.1%
- 2022$186.99M+20.3%
- 2021$155.41M-7.9%
- 2020$168.65M+252.4%
- 2019$47.86M—
Total Liabilities values are taken from Tango Therapeutics's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at Tango Therapeutics (TNGX)
According to Tango Therapeutics's latest reported financial statements, the company's latest reported total liabilities is $44.29M. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total liabilities for Tango Therapeutics (TNGX) came in at $52.51M – plunged 55.1% year-over-year.
Across 2020–2025 (5 years), Tango Therapeutics total liabilities produced a CAGR of -20.8% – with a net decline across the window.
The highest annual total liabilities of $186.99M was reported in 2022. The lowest in the available history was $47.86M in 2019.
Tango Therapeutics Total Liabilities by Year
Tango Therapeutics Total Liabilities 2025: $52.51M
2025's total liabilities for Tango Therapeutics came in at $52.51M, plunged 55.1% below 2024.
Tango Therapeutics Total Liabilities 2024: $116.97M
Tango Therapeutics posted total liabilities of $116.97M in 2024, declined 21.7% below 2023.
Tango Therapeutics Total Liabilities 2023: $149.46M
In 2023, Tango Therapeutics reported total liabilities of $149.46M, declined 20.1% below 2022.
Tango Therapeutics Total Liabilities 2022: $186.99M
Tango Therapeutics total liabilities in 2022 was $186.99M, grew 20.3% from 2021. This figure represents the highest annual value in the available history.
Tango Therapeutics Total Liabilities 2021: $155.41M
Tango Therapeutics total liabilities in 2021 was $155.41M.
See more financial history for Tango Therapeutics (TNGX).
Sector peers by Total Liabilities
Healthcare peers of Tango Therapeutics (TNGX), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $84.20B | |
| $81.93B | |
| $65.36B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $84.20B
- $81.93B
- $65.36B
- $54.86B
Frequently asked questions
Tango Therapeutics (TNGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation